(Reuters) - The biotechnology company, in a statement, said it had originally anticipated a decision by this time. It said it hopes a decision would come within the next 60 to 90 days.
In October, the regulators denied Cytomedix's claim that AutoloGel was substantially equivalent to a legally marketed device.
Read more at Reuters.com Market News
In October, the regulators denied Cytomedix's claim that AutoloGel was substantially equivalent to a legally marketed device.
Read more at Reuters.com Market News
No comments:
Post a Comment